Sign in
4

Changes in Ownership

HAEMONETICS CORP Filed Acc 0001127602-19-006806

Director sold 8,196 shares at $86.52 ($709,118)

  • Director acquired 8,196 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

GELBMAN RONALD G · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-02-15 Exercise or conversion : show line 1 in the form +8,196 $36.37 $298,089 61,258 D
2019-02-15 Sale : show line 2 in the form −8,196 $86.52 $709,118 53,062 D
Open-market sales · 8,196 sh · avg $86.52 · $709,118

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-02-15 Exercise or conversion : show line 3 in the form Non-qualified Stock Option (Right to Buy) −8,196 0 D
Loading xslF345X03/form4.xml…